Thyroid-stimulating Hormone Suppression Therapy

Overview

Thyroid-stimulating hormone suppression therapy is a treatment strategy used in differentiated Thyroid Cancer management where levothyroxine is administered to reduce circulating TSH levels, thereby limiting stimulation of any remaining thyroid tissue or cancer cells after surgery. Research published in this journal examines clinical outcomes in differentiated Thyroid Cancer patients who undergo comprehensive treatment including surgery and radioactive iodine therapy, evaluating the effectiveness of these combined approaches in specific clinical settings. The journal has also addressed practical safety considerations surrounding radioactive iodine ablation, specifically investigating household radiation exposure levels when this therapy is administered in ambulatory settings rather than requiring inpatient hospitalization. This topic matters because TSH suppression therapy represents a cornerstone of long-term management for many Thyroid Cancer patients, and optimizing treatment protocols requires understanding both therapeutic efficacy and safety implications for patients and their families. The balance between adequate disease control and minimizing treatment-related risks remains an important consideration in clinical practice, particularly as treatment paradigms evolve to include outpatient radioiodine administration and risk-stratified approaches to TSH suppression intensity.

Research published in this journal

2 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 2 articles above have been cited 8 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Measurement of Radiation Exposure to Caregivers of Patients with Thyroid Diseases Treated with Iodine-131: A Review
  Ali Abdulhasan Kadhim et al. · 2020 ·
• Radiation Dose Assessment to Family Members Taking Care of Non-Cancerous Thyroid Patients Treated with I-131 Therapy in Nuclear Medicine Department.
  Ali Abdulhasan Kadhim et al. · 2020 · Radiation Protection Dosimetry
• Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)
  K. Salman et al. · 2020 · Journal of the Egyptian National Cancer Institute
• Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)
  2020 · Journal of the Egyptian National Cancer Institute
• RADIATION DOSE ASSESSMENT TO FAMILY MEMBERS TAKING CARE OF NON-CANCEROUS THYROID PATIENTS TREATED WITH I-131 THERAPY IN NUCLEAR MEDICINE DEPARTMENT
  2020 · Radiation Protection Dosimetry
• Measurement of radiation exposure to household contacts of patients with Graves’ disease treated with low dose radioactive iodine (131I) on outpatient basis
  K. Salman et al. · 2018 · The Egyptian Journal of Radiology and Nuclear Medicine
• Measurement of External Radiation Exposure to Household Contacts of Outpatients Treated with Radioactive Iodine (131I).
  Salman et al. · 2018 ·
• Measurement of radiation exposure to household contacts of patients with Graves’ disease treated with low dose radioactive iodine (131I) on outpatient basis
  2018 · The Egyptian Journal of Radiology and Nuclear Medicine

A sample of recent works citing this journal's research on Thyroid-stimulating Hormone Suppression Therapy, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics